Solange Peters, MD-PhD

Trials

Studies that name Solange Peters, MD-PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:18 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT06284317 · A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.

  ETOP IBCSG Partners Foundation · recruiting · Non Small Cell Lung Cancer · study chair
• Ph2
  NCT02434081 · NIvolumab COmbination With Standard First-line Chemotherapy and Radiotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Carcinoma

  ETOP IBCSG Partners Foundation · completed · Non-small Cell Lung Cancer Stage III
• Ph2
  NCT02369484 · Afatinib in NSCLC With HER2 Mutation

  ETOP IBCSG Partners Foundation · completed · NSCLC · study chair
• Ph3
  NCT02129699 · Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy

  ETOP IBCSG Partners Foundation · terminated · Lung Cancer Non-small Cell Stage IV
• Ph2
  NCT02046733 · Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

  ETOP IBCSG Partners Foundation · completed · Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
• Ph3
  NCT01652469 · Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.

  ETOP IBCSG Partners Foundation · completed · Carcinoma, Non-Small-Cell Lung · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.